March 27, 2017 — Using genetic testing to help personalize warfarin therapy given to patients undergoing elective ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 24, 2017 — Safe implementation of new technologies and therapies accompany classic patient safety challenges on ...
March 23, 2017 — Bleeding complications did not increase for patients with acute coronary syndrome treated with ...
March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low dose ...
March 22, 2017 — In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when ...
March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots ...
March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...
March 14, 2017 — More than 80 percent of stroke patients with a history of atrial fibrillation either received not ...
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF ...
February 22, 2017 — The American College of Cardiology (ACC), Haymarket Medical Education (HME) and myCME have joined ...
February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopping ...
February 7, 2017 — GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma ...
January 17, 2017 — Warfarin is a commonly prescribed blood thinner used to prevent harmful blood clots. However, the ...
January 11, 2017 — For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of ...
Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology and ...